EP Patent

EP2033643A1 — Compressed preparation

Assigned to Daiichi Sankyo Co Ltd · Expires 2009-03-11 · 17y expired

What this patent protects

[Object] The present invention provides an olmesartan medoxomil-containing drug product having an improved dissolution property. [Means for Solution] A production method for an olmesartan medoxomil-containing drug product characterized in that the method compr…

USPTO Abstract

[Object] The present invention provides an olmesartan medoxomil-containing drug product having an improved dissolution property. [Means for Solution] A production method for an olmesartan medoxomil-containing drug product characterized in that the method comprises a process of compressing a composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP2033643A1
Jurisdiction
EP
Classification
—
Expires
2009-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Daiichi Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.